These drugs can slow the progression of psoriatic arthritis and save joints and other tissues from permanent damage. The most commonly used DMARD is methotrexate (Trexall, Otrexup, others). Others include leflunomide (Arava) and sulfasalazine (Azulfidine).
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Psoriatic Arthritis Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Market Segment by Product Application
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Finally, the report provides detailed profile and data information analysis of leading company.
Abbvie
Janssen
Amgen
Pfizer
Eli-lilly
Celgene
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Psoriatic Arthritis Drugs consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Psoriatic Arthritis Drugs market by identifying its various subsegments.
3.Focuses on the key global Psoriatic Arthritis Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Psoriatic Arthritis Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Psoriatic Arthritis Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Psoriatic Arthritis Drugs Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Psoriatic Arthritis Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Psoriatic Arthritis Drugs Segment by Type
2.1.1 TNF Inhibitors
2.1.2 PDE4 Inhibitors
2.1.3 Interleukin Blockers
2.1.4 Other
2.2 Market Analysis by Application
2.2.1 Mild Psoriatic Arthritis
2.2.2 Moderate Psoriatic Arthritis
2.2.3 Severe Psoriatic Arthritis
2.3 Global Psoriatic Arthritis Drugs Market Comparison by Regions (2016-2026)
2.3.1 Global Psoriatic Arthritis Drugs Market Size (2016-2026)
2.3.2 North America Psoriatic Arthritis Drugs Status and Prospect (2016-2026)
2.3.3 Europe Psoriatic Arthritis Drugs Status and Prospect (2016-2026)
2.3.4 China Psoriatic Arthritis Drugs Status and Prospect (2016-2026)
2.3.5 Japan Psoriatic Arthritis Drugs Status and Prospect (2016-2026)
2.3.6 Southeast Asia Psoriatic Arthritis Drugs Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Psoriatic Arthritis Drugs Industry Impact
2.5.1 Psoriatic Arthritis Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Psoriatic Arthritis Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Psoriatic Arthritis Drugs Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Psoriatic Arthritis Drugs Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Psoriatic Arthritis Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Psoriatic Arthritis Drugs Manufacturer Market Share
3.5 Top 10 Psoriatic Arthritis Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Psoriatic Arthritis Drugs Market
3.7 Key Manufacturers Psoriatic Arthritis Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Psoriatic Arthritis Drugs Industry Key Manufacturers
4.1 Abbvie
4.1.1 Compan Detail
4.1.2 Abbvie Psoriatic Arthritis Drugs Product Introduction, Application and Specification
4.1.3 Abbvie 136 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Abbvie News
4.2 Janssen
4.2.1 Compan Detail
4.2.2 Janssen Psoriatic Arthritis Drugs Product Introduction, Application and Specification
4.2.3 Janssen Psoriatic Arthritis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Abbvie News
4.3 Amgen
4.3.1 Compan Detail
4.3.2 Amgen Psoriatic Arthritis Drugs Product Introduction, Application and Specification
4.3.3 Amgen Psoriatic Arthritis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Amgen News
4.4 Pfizer
4.4.1 Compan Detail
4.4.2 Pfizer Psoriatic Arthritis Drugs Product Introduction, Application and Specification
4.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Pfizer News
4.5 Eli-lilly
4.5.1 Compan Detail
4.5.2 Pfizer Psoriatic Arthritis Drugs Product Introduction, Application and Specification
4.5.3 Eli-lilly Psoriatic Arthritis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Eli-lilly News
4.6 Celgene
4.6.1 Compan Detail
4.6.2 Celgene Psoriatic Arthritis Drugs Product Introduction, Application and Specification
4.6.3 Celgene Psoriatic Arthritis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Celgene News
5 Global Psoriatic Arthritis Drugs Market Segment by Big Type
5.1 Global Psoriatic Arthritis Drugs Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Psoriatic Arthritis Drugs Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Psoriatic Arthritis Drugs Revenue and Market Share by Big Type (2016-2021)
5.2 TNF Inhibitors Sales Growth Rate and Price
5.2.1 Global TNF Inhibitors Sales Growth Rate (2016-2021)
5.2.2 Global TNF Inhibitors Price (2016-2021)
5.3 PDE4 Inhibitors Sales Growth Rate and Price
5.3.1 Global PDE4 Inhibitors Sales Growth Rate (2016-2021)
5.3.2 Global PDE4 Inhibitors Price (2016-2021)
5.4 Interleukin Blockers Sales Growth Rate and Price
5.4.1 Global Interleukin Blockers Sales Growth Rate (2016-2021)
5.4.2 Global Interleukin Blockers Price (2016-2021)
5.5 Other Sales Growth Rate and Price
5.5.1 Global Other Sales Growth Rate (2016-2021)
5.5.2 Global Other Price (2016-2021)
6 Global Psoriatic Arthritis Drugs Market Segment by Big Application
6.1 Global Psoriatic Arthritis Drugs Sales Market Share by Big Application (2016-2021)
6.2 Mild Psoriatic Arthritis Sales Growth Rate (2016-2021)
6.3 Moderate Psoriatic Arthritis Sales Growth Rate (2016-2021)
6.4 Severe Psoriatic Arthritis Sales Growth Rate (2016-2021)
7 Global Psoriatic Arthritis Drugs Forecast
7.1 Global Psoriatic Arthritis Drugs Revenue, Sales and Growth Rate (2021-2026)
7.2 Psoriatic Arthritis Drugs Market Forecast by Regions (2021-2026)
7.2.1 North America Psoriatic Arthritis Drugs Market Forecast (2021-2026)
7.2.2 Europe Psoriatic Arthritis Drugs Market Forecast (2021-2026)
7.2.3 China Psoriatic Arthritis Drugs Market Forecast (2021-2026)
7.2.4 Japan Psoriatic Arthritis Drugs Market Forecast (2021-2026)
7.2.5 Southeast Asia Psoriatic Arthritis Drugs Market Forecast (2021-2026)
7.2.6 Other Regions Psoriatic Arthritis Drugs Market Forecast (2021-2026)
7.3 Psoriatic Arthritis Drugs Market Forecast by Type (2021-2026)
7.3.1 Global Psoriatic Arthritis Drugs Sales Forecast by Type (2021-2026)
7.3.2 Global Psoriatic Arthritis Drugs Market Share Forecast by Type (2021-2026)
7.4 Psoriatic Arthritis Drugs Market Forecast by Application (2021-2026)
7.4.1 Global Psoriatic Arthritis Drugs Sales Forecast by Application (2021-2026)
7.4.2 Global Psoriatic Arthritis Drugs Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Psoriatic Arthritis Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Psoriatic Arthritis Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Psoriatic Arthritis Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Psoriatic Arthritis Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Psoriatic Arthritis Drugs Market Size by Big Type
Figure Global Market Share of Psoriatic Arthritis Drugs by Big Type in 2020
Figure TNF Inhibitors Picture (2016-2021)
Figure PDE4 Inhibitors Picture (2016-2021)
Figure Interleukin Blockers Picture (2016-2021)
Global Psoriatic Arthritis Drugs Market Size by Big Application
Table Global Psoriatic Arthritis Drugs Market Size by Application
Figure Global Psoriatic Arthritis Drugs Market Share by Big Application in 2020
Figure Mild Psoriatic Arthritis Picture
Figure Moderate Psoriatic Arthritis Picture
Figure Severe Psoriatic Arthritis Picture
Table Global Psoriatic Arthritis Drugs Comparison by Regions (M USD) (2016-2026)
Figure Global Psoriatic Arthritis Drugs Market Size (Million US$) (2016-2026)
Figure North America Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure China Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Psoriatic Arthritis Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Psoriatic Arthritis Drugs Sales by Manufacturer (2016-2021)
Figure Global Psoriatic Arthritis Drugs Sales Market Share by Manufacturer in 2020
Table Global Psoriatic Arthritis Drugs Revenue by Manufacturer (2016-2021)
Figure Global Psoriatic Arthritis Drugs Revenue Market Share by Manufacturer in 2020
Table Global Psoriatic Arthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Psoriatic Arthritis Drugs Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Psoriatic Arthritis Drugs Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Psoriatic Arthritis Drugs Market
Table Key Manufacturers Psoriatic Arthritis Drugs Product Type
Table Mergers & Acquisitions Planning
Table Abbvie Company Profile
Table Psoriatic Arthritis Drugs Product Introduction, Application and Specification of Abbvie
Table Psoriatic Arthritis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Janssen Company Profile
Table Psoriatic Arthritis Drugs Product Introduction, Application and Specification of Janssen
Table Psoriatic Arthritis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Janssen Recent Development
Table Amgen Company Profile
Table Psoriatic Arthritis Drugs Product Introduction, Application and Specification of Amgen
Table Psoriatic Arthritis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Amgen Main Business
Table Amgen Recent Development
Table Pfizer Company Profile
Table Psoriatic Arthritis Drugs Product Introduction, Application and Specification of Pfizer
Table Psoriatic Arthritis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Pfizer Main Business
Table Pfizer Recent Development
Table Pfizer Main Business
Table Pfizer Recent Development
Table Eli-lilly Company Profile
Table Psoriatic Arthritis Drugs Product Introduction, Application and Specification of Eli-lilly
Table Psoriatic Arthritis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Eli-lilly Main Business
Table Eli-lilly Recent Development
Table Celgene Company Profile
Table Psoriatic Arthritis Drugs Product Introduction, Application and Specification of Celgene
Table Psoriatic Arthritis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Celgene Main Business
Table Celgene Recent Development
Figure Global Psoriatic Arthritis Drugs Sales and Growth Rate (2016-2021)
Figure Global Psoriatic Arthritis Drugs Revenue and Growth Rate (2016-2021)
Table Global Psoriatic Arthritis Drugs Sales by Regions (2016-2021)
Figure Global Psoriatic Arthritis Drugs Sales Market Share by Regions in 2020
Table Global Psoriatic Arthritis Drugs Revenue by Regions (2016-2021)
Figure Global Psoriatic Arthritis Drugs Revenue Market Share by Regions in 2020
Figure North America Psoriatic Arthritis Drugs Sales and Growth Rate (2016-2021)
Figure Europe Psoriatic Arthritis Drugs Sales and Growth Rate (2016-2021)
Figure China Psoriatic Arthritis Drugs Sales and Growth Rate (2016-2021)
Figure Japan Psoriatic Arthritis Drugs Sales and Growth Rate (2016-2021)
Figure Southeast Asia Psoriatic Arthritis Drugs Sales and Growth Rate (2016-2021)
Figure Other Regions Psoriatic Arthritis Drugs Sales and Growth Rate (2016-2021)
Table Global Psoriatic Arthritis Drugs Sales by Big Type (2016-2021)
Table Global Psoriatic Arthritis Drugs Sales Market Share by Big Type (2016-2021)
Figure Global Psoriatic Arthritis Drugs Sales Market Share by Big Type in 2019
Table Global Psoriatic Arthritis Drugs Revenue by Big Type (2016-2021)
Table Global Psoriatic Arthritis Drugs Revenue Market Share by Big Type (2016-2021)
Table Global Psoriatic Arthritis Drugs Revenue Market Share by Big Type in 2019
Figure Global TNF Inhibitors Sales Growth Rate (2016-2021)
Figure Global TNF Inhibitors Price (2016-2021)
Figure Global PDE4 Inhibitors Sales Growth Rate (2016-2021)
Figure Global PDE4 Inhibitors Price (2016-2021)
Figure Global Interleukin Blockers Sales Growth Rate (2016-2021)
Figure Global Interleukin Blockers Price (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Table Global Psoriatic Arthritis Drugs Sales by Big Application (2016-2021)
Table Global Psoriatic Arthritis Drugs Sales Market Share by Big Application (2016-2021)
Figure Global Psoriatic Arthritis Drugs Sales Market Share by Big Application in 2019
Figure Global Mild Psoriatic Arthritis Sales Growth Rate (2016-2021)
Figure Global Moderate Psoriatic Arthritis Sales Growth Rate (2016-2021)
Figure Global Severe Psoriatic Arthritis Sales Growth Rate (2016-2021)
Figure Global Psoriatic Arthritis Drugs Sales and Growth Rate (2021-2026)
Figure Global Psoriatic Arthritis Drugs Revenue and Growth Rate (2021-2026)
Table Global Psoriatic Arthritis Drugs Sales Forecast by Regions (2021-2026)
Table Global Psoriatic Arthritis Drugs Market Share Forecast by Regions (2021-2026)
Figure North America Sales Psoriatic Arthritis Drugs Market Forecast (2021-2026)
Figure Europe Sales Psoriatic Arthritis Drugs Market Forecast (2021-2026)
Figure China Sales Psoriatic Arthritis Drugs Market Forecast (2021-2026)
Figure Japan Sales Psoriatic Arthritis Drugs Market Forecast (2021-2026)
Figure Southeast Asia Sales Psoriatic Arthritis Drugs Market Forecast (2021-2026)
Figure Other Regions Sales Psoriatic Arthritis Drugs Market Forecast (2021-2026)
Table Global Psoriatic Arthritis Drugs Sales Forecast by Type (2021-2026)
Table Global Psoriatic Arthritis Drugs Market Share Forecast by Type (2021-2026)
Table Global Psoriatic Arthritis Drugs Sales Forecast by Application (2021-2026)
Table Global Psoriatic Arthritis Drugs Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Psoriatic Arthritis Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Psoriatic Arthritis Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Psoriatic Arthritis Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Psoriatic Arthritis Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Psoriatic Arthritis Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Psoriatic Arthritis Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Abbvie
Janssen
Amgen
Pfizer
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)